Key Points:

• The October 20, 2026, IPO calendar lists three expected pricings, spanning a trust structure, a growth-oriented exchange-traded fund, and a perpetual preferred stock offering.
• MayTech Global Growth ETF and Strive’s Series A Perpetual SATS Preferred Stock are listed on Nasdaq, while Tidal Trust V is scheduled for NYSE Arca.
• The calendar provides no offering prices, deal sizes, valuations, or investor-demand figures, limiting conclusions about the strength of the U.S. IPO market.

Three Expected Pricings Define the Day’s Scheduled Activity

The U.S. IPO calendar for Tuesday, October 20, 2026, lists three expected pricing events: Tidal Trust V (AIBN), MayTech Global Growth ETF (MTGG), and Strive, Inc. 15% Series A Perpetual SATS Preferred Stock (SATS). The entries represent different types of publicly traded securities rather than three conventional operating-company IPOs. That distinction matters when assessing the breadth of capital-market activity, since exchange-traded funds, trust vehicles, and preferred securities serve different investor needs and follow different valuation considerations.

The calendar records all three events as expected, not completed. It provides no final pricing information or transaction sizes, so the listings should be treated as scheduled activity rather than confirmed capital raised.

Nasdaq and NYSE Arca Host Different Securities

Two of the scheduled offerings are associated with Nasdaq. MTGG is identified as MayTech Global Growth ETF, while SATS represents Strive, Inc. 15% Series A Perpetual SATS Preferred Stock. Tidal Trust V, trading under AIBN, is listed on NYSE Arca. The exchange distribution illustrates the range of securities entering public markets, although the calendar alone does not establish how much investor capital each transaction is expected to attract.

The distinction is especially relevant for SATS, whose stated 15% designation and perpetual structure set it apart from a conventional common-stock offering. Preferred securities can have different income, distribution, and risk characteristics from ordinary shares. However, the supplied calendar does not provide the full terms needed to assess its distribution obligations, redemption provisions, or other contractual features. Those details would be necessary before drawing conclusions about the security’s appeal or cost of capital.

Limited Pricing Data Restricts Conclusions About Demand

The three entries offer a snapshot of scheduled issuance but do not establish whether investor demand is strengthening or weakening. No offer prices, share counts, proceeds estimates, valuation figures, subscription data, or order-book details are included. Without those measures, it is not possible to determine whether the transactions are attracting strong demand, pricing at a premium, or meeting resistance from investors.

The distinction between scheduled pricing and completed issuance is also important. A calendar entry can change as transaction timetables evolve, and an expected pricing date does not by itself confirm that an offering has closed or begun trading. Official offering documents and subsequent exchange updates would be needed to establish final terms and execution.

The Next Test Is Confirmation of Final Terms

Attention should now turn to whether the three expected pricings proceed as scheduled and what their final terms reveal. Confirmed prices, transaction structures, and trading activity would provide a stronger basis for evaluating investor appetite than calendar entries alone. Broader conclusions about U.S. IPO momentum will require additional evidence from conventional company listings, offering sizes, pricing relative to proposed ranges, and early aftermarket performance. Until those details emerge, October 20 represents a day of varied scheduled issuance rather than a definitive signal of a broader IPO-market reopening.